Rekah Pharmaceutical Industry Ltd (REKA) — Tangible Net Worth Ratio
Rekah Pharmaceutical Industry Ltd (REKA) has a Tangible Net Worth Ratio of 86.3% as of June 2026. This metric is calculated by deducting intangible assets (ILA19.15 Million) from net assets (ILA140.18 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore REKA year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Rekah Pharmaceutical Industry Ltd Tangible Net Worth Ratio (2004–2025)
This chart shows how Rekah Pharmaceutical Industry Ltd's Tangible Net Worth Ratio has changed across 22 annual periods from 2004 to 2025. As of June 2026, the ratio stands at 86.3%, reflecting net assets of ILA140.18 Million with intangible assets of ILA19.15 Million ILA. For live market cap and overall valuation, see Rekah Pharmaceutical Industry Ltd (REKA) total market value.
Annual Tangible Net Worth Ratio for Rekah Pharmaceutical Industry Ltd (2004–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Rekah Pharmaceutical Industry Ltd from 2004 to 2025, covering 22 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore REKA capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (ILA) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 61.0% | ILA144.21 Million | ILA56.27 Million | ILA423.68 Million | ▼ -1.5 pp |
| 2024 | 62.4% | ILA161.98 Million | ILA60.84 Million | ILA447.22 Million | ▼ -17.2 pp |
| 2023 | 79.6% | ILA155.59 Million | ILA31.66 Million | ILA484.72 Million | ▼ -7.6 pp |
| 2022 | 87.2% | ILA162.08 Million | ILA20.67 Million | ILA448.42 Million | ▲ +6.3 pp |
| 2021 | 81.0% | ILA173.06 Million | ILA32.97 Million | ILA437.09 Million | ▼ -16.5 pp |
| 2020 | 97.5% | ILA165.59 Million | ILA4.18 Million | ILA419.69 Million | ▼ -1.0 pp |
| 2019 | 98.4% | ILA155.22 Million | ILA2.44 Million | ILA367.11 Million | ▼ -0.1 pp |
| 2018 | 98.5% | ILA150.66 Million | ILA2.21 Million | ILA300.28 Million | ▲ +0.1 pp |
| 2017 | 98.4% | ILA144.62 Million | ILA2.33 Million | ILA294.95 Million | ▼ -0.4 pp |
| 2016 | 98.8% | ILA105.86 Million | ILA1.26 Million | ILA322.72 Million | ▼ -0.3 pp |
| 2015 | 99.2% | ILA123.66 Million | ILA1.04 Million | ILA323.82 Million | ▲ +0.9 pp |
| 2014 | 98.2% | ILA77.06 Million | ILA1.37 Million | ILA310.11 Million | ▲ +1.5 pp |
| 2013 | 96.7% | ILA79.51 Million | ILA2.61 Million | ILA303.16 Million | ▲ +0.5 pp |
| 2012 | 96.2% | ILA71.17 Million | ILA2.71 Million | ILA298.07 Million | ▲ +1.0 pp |
| 2011 | 95.2% | ILA64.00 Million | ILA3.08 Million | ILA286.99 Million | ▲ +0.7 pp |
| 2010 | 94.5% | ILA63.78 Million | ILA3.51 Million | ILA287.97 Million | ▲ +1.0 pp |
| 2009 | 93.5% | ILA64.15 Million | ILA4.17 Million | ILA278.40 Million | ▲ +1.6 pp |
| 2008 | 91.9% | ILA58.62 Million | ILA4.72 Million | ILA290.50 Million | ▼ -2.3 pp |
| 2007 | 94.2% | ILA67.10 Million | ILA3.89 Million | ILA300.96 Million | ▼ -0.4 pp |
| 2006 | 94.6% | ILA61.54 Million | ILA3.35 Million | ILA296.53 Million | ▼ -1.7 pp |
| 2005 | 96.2% | ILA58.85 Million | ILA2.22 Million | ILA267.00 Million | ▲ +3.0 pp |
| 2004 | 93.2% | ILA48.86 Million | ILA3.30 Million | ILA202.04 Million | — |